NewAmsterdam Pharma (NAMSW) Short Interest Ratio & Short Volume $9.58 +0.76 (+8.62%) As of 06/20/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestTrendsBuy This Stock NewAmsterdam Pharma Short Interest DataNewAmsterdam Pharma (NAMSW) has a short interest of 100 shares. This marks a -50.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 5,125 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest200 sharesChange Vs. Previous Month-50.00%Dollar Volume Sold Short$1.25 thousandShort Interest Ratio0.0 Days to CoverLast Record DateJanuary 15, 2025Today's Trading Volume4,008 sharesAverage Trading Volume5,125 sharesToday's Volume Vs. Average78% Short Selling NewAmsterdam Pharma? Sign up to receive the latest short interest report for NewAmsterdam Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNAMSW Short Interest Over TimeNAMSW Days to Cover Over TimeNAMSW Percentage of Float Shorted Over Time NewAmsterdam Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/2025100 shares $1.25 thousand -50.0%N/A0 $12.50 12/31/2024200 shares $2.85 thousand No ChangeN/A0 $14.25 12/15/2024200 shares $2.60 thousand -80.0%N/A0 $13.02 11/30/20241,000 shares $9.06 thousand -71.4%N/A0.1 $9.06 11/15/20243,500 shares $46.55 thousand -30.0%N/A0.6 $13.30 10/31/20245,000 shares $43.50 thousand -16.7%N/A1.2 $8.70 10/15/20246,000 shares $51 thousand -52.8%N/A1.9 $8.50 9/30/202412,700 shares $88.90 thousand +58.8%N/A3.7 $7.00 9/15/20248,000 shares $53.68 thousand -3.6%N/A2.2 $6.71 8/31/20248,300 shares $56.77 thousand +33.9%N/A1.9 $6.84 Get the Latest News and Ratings for NAMSW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. 8/15/20246,200 shares $47.37 thousand +1,966.7%N/A1.4 $7.64 7/31/2024300 shares $1.95 thousand -97.6%N/A0.1 $6.50 7/15/202412,500 shares $118.13 thousand -33.9%N/A3.9 $9.45 6/30/202418,900 shares $164.81 thousand +56.2%N/A6.1 $8.72 6/15/202412,100 shares $108.90 thousand +21.0%N/A2.2 $9.00 5/31/202410,000 shares $79.00 thousand +25.0%N/A1.4 $7.90 5/15/20248,000 shares $72 thousand -11.1%N/A0.8 $9.00 4/30/20249,000 shares $94.50 thousand -32.3%N/A0.9 $10.50 4/15/202413,300 shares $139.65 thousand +66.3%N/A1.1 $10.50 3/31/20248,000 shares $88.32 thousand -30.4%N/A0.4 $11.04 3/15/202411,500 shares $120.87 thousand -13.5%N/A0.7 $10.51 2/29/202413,300 shares $143.51 thousand +79.7%N/A1 $10.79 2/15/20247,400 shares $65.93 thousand -31.5%N/A0.6 $8.91 1/31/202410,800 shares $100.98 thousand -70.7%N/A1 $9.35 1/15/202436,800 shares $227.42 thousand +0.6%N/A3.3 $6.18 12/31/202336,600 shares $114.56 thousand +5.2%N/A6.8 $3.13 12/15/202334,800 shares $85.61 thousand -1.1%N/A6.3 $2.46 11/30/202335,200 shares $82.37 thousand +13.6%N/A4.2 $2.34 11/15/202331,000 shares $68.20 thousand -37.5%N/A3.3 $2.20 10/31/202349,600 shares $86.80 thousand +12.7%N/A4.7 $1.75 10/15/202344,000 shares $61.60 thousand +53.9%N/A4.3 $1.40 9/30/202328,600 shares $54.34 thousand +23.3%N/A1.8 $1.90 9/15/202323,200 shares $43.85 thousand +91.7%N/A1.5 $1.89 8/31/202312,100 shares $24.20 thousand -20.9%N/A0.7 $2.00 8/15/202315,300 shares $31.37 thousand +183.3%N/A0.7 $2.05 7/31/20235,400 shares $11.07 thousand -3.6%N/A0.2 $2.05 7/15/20235,600 shares $11.20 thousand +180.0%N/A0.2 $2.00 6/30/20232,000 shares $4.18 thousand -16.7%N/A0.1 $2.09 6/15/20232,400 shares $4.85 thousand +84.6%N/A0.1 $2.02 5/31/20231,300 shares $2.93 thousand -79.4%N/A0.1 $2.25Gold is soaring. Here’s how to get paid from it (Ad)Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.Click here to discover the income ETF behind it all. 5/15/20236,300 shares $8.06 thousand No ChangeN/A0.4 $1.28 NAMSW Short Interest - Frequently Asked Questions What is NewAmsterdam Pharma's current short interest? Short interest is the volume of NewAmsterdam Pharma shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 100 shares of NAMSW short. Learn More on NewAmsterdam Pharma's current short interest. Is NewAmsterdam Pharma's short interest increasing or decreasing? NewAmsterdam Pharma saw a decrease in short interest in January. As of January 15th, there was short interest totaling 100 shares, a decrease of 50.0% from the previous total of 200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper Company ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short NewAmsterdam Pharma stock? Short selling NAMSW is an investing strategy that aims to generate trading profit from NewAmsterdam Pharma as its price is falling. NAMSW shares are trading up $0.76 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NewAmsterdam Pharma? A short squeeze for NewAmsterdam Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NAMSW, which in turn drives the price of the stock up even further. How often is NewAmsterdam Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NAMSW, twice per month. The most recent reporting period available is January, 15 2025. More Short Interest Resources from MarketBeat Related Companies APLMW Short Squeeze BCTXW Short Squeeze CDIOW Short Squeeze CEROW Short Squeeze CLNNW Short Squeeze CMRAW Short Squeeze CDTTW Short Squeeze EFTRW Short Squeeze ENGNW Short Squeeze FBIOP Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NAMSW) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored379 passengers walked away from thisForget OpenAI, ChatGPT, and the $2 trillion chip race… The real story is buried inside a new U.S. patent. E...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewAmsterdam Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Share NewAmsterdam Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NAMSW Stock Free NAMSW Stock Alerts